Cargando…
Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma
BACKGROUND: The purpose of the study was to evaluate the effect of radiation therapy and chemoradiation with gemcitabine (GEM) after R1 resection in patients with pancreatic adenocarcinoma (PAC). METHODS: We performed a retrospective analysis of 25 patients who were treated with postoperative radiot...
Autores principales: | Habermehl, Daniel, Brecht, Ingo C, Bergmann, Frank, Rieken, Stefan, Werner, Jens, Büchler, Markus W, Springfeld, Christoph, Jäger, Dirk, Debus, Jürgen, Combs, Stephanie E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404664/ https://www.ncbi.nlm.nih.gov/pubmed/25889749 http://dx.doi.org/10.1186/s12957-015-0560-3 |
Ejemplares similares
-
Chemoradiation in patients with isolated recurrent pancreatic cancer - therapeutical efficacy and probability of re-resection
por: Habermehl, Daniel, et al.
Publicado: (2013) -
Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer
por: Habermehl, Daniel, et al.
Publicado: (2012) -
In vitro evaluation of photon and raster-scanned carbon ion radiotherapy in combination with gemcitabine in pancreatic cancer cell lines
por: El Shafie, Rami A., et al.
Publicado: (2013) -
Phase I study evaluating the treatment of patients with locally advanced pancreatic cancer with carbon ion radiotherapy: the PHOENIX-01 trial
por: Combs, Stephanie E, et al.
Publicado: (2013) -
Palliative radiation therapy in patients with metastasized pancreatic cancer - description of a rare patient group
por: Habermehl, Daniel, et al.
Publicado: (2014)